Impax Laboratories, Inc Jobs and Profile

Impax Laboratories, Inc. is a technology-based, specialty pharmaceutical company applying its formulation expertise and drug delivery technology to the development of controlled-release and specialty Generics in addition to the development of Branded products. 

Impax Laboratories, Inc. is headquartered in Hayward, CA, with additional locations in Pennsylvania and Jhunan Science Park, Taiwan, with both Domestic and International career opportunities available

Mission Statement

IMPAX Laboratories will become a leader in the development, manufacturing and marketing of prescription pharmaceutical products utilizing our formulation expertise and unique drug delivery technologies. We will focus on those opportunities that increase shareholder value and provide long-term profitable growth.   Company History On December 14, 1999, Global Pharmaceutical Corporation and privately-held IMPAX Pharmaceuticals, Inc. completed a reverse merger, forming a new organization called Impax Laboratories, Inc. The merger combined the advanced drug delivery systems developed by IMPAX Pharmaceuticals through its research and development capabilities with Global Pharmaceutical’s sales, marketing and distribution capabilities. The synergy created by the merger provided the foundation for the current and future success of the organization. Since 1999, the company has continued to increase sales of existing products, consistently filed between 6-8 drug applications with the Food and Drug Administration (FDA) annually, and has received tentative and final approval from the FDA for numerous products. Where strategically appropriate, IMPAX has developed marketing partnerships to fully leverage its technology platform in order to maximize product revenues and profitability. IMPAX also has two marketing divisions of its own for it’s products. Its Global Pharmaceuticals division sells generic products, while the branded products will be marketed through the Impax Pharmaceuticals division.   International Operations Impax Laboratories (Taiwan), Inc., a wholly owned subsidiary of Impax Laboratories, Inc., is located in Jhunan Science Park, Taiwan. Impax Laboratories, Inc. is a U.S. Nasdaq-listed company. It is a technology-based specialty pharmaceutical company applying its formulation and clinical development expertise and drug delivery technology to the development, manufacturing and distribution of controlled-release and specialty generics and branded prescription drugs. Impax Laboratories currently has more than 40 generic products on the U.S. market with additional 28 ANDAs pending at FDA for approval and 43 generic products under development. Most of these products are controlled-release or difficult-to-formulate products. Impax Laboratories also has two brand product candidates in phase III clinical trials targeting Parkinson’s Disease and Multiple Sclerosis patients.